Hormone Receptor Expression in Renal Angiomyolipoma: Clinicopathologic Correlation

Urology

Volumn 72, Issue 4, 2008, Pages 927-932

  Boorjian, Stephen A ^a   Sheinin, Yuri ^a,b   Crispen, Paul L ^a   Lohse, Christine M ^a   Kwon, Eugene D ^a,b   Leibovich, Bradley C ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; AROMATASE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HORMONE RECEPTOR; MONOCLONAL ANTIBODY; PARAFFIN; PROGESTERONE RECEPTOR;

ADULT; AGED; ANGIOMYOLIPOMA; ARTICLE; COMPARATIVE STUDY; CORRELATION ANALYSIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY SURGERY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SECTION; TUBEROUS SCLEROSIS;

ADULT; AGED; AGED, 80 AND OVER; ANGIOMYOLIPOMA; AROMATASE; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 52949129082     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.01.067     Document Type: Article

References (30)

1. Lemaitre L., Robert Y., Dubrulle F., et al. Renal angiomyolipoma: growth followed up with CT and/or US. Radiology 197 (1995) 598-602
2. Nelson C.P., and Sanda M.G. Contemporary diagnosis and management of renal angiomyolipoma. J Urol 168 (2002) 1315-1325
3. Hajdu S.I., and Foote Jr. F.W. Angiomyolipoma of the kidney: report of 27 cases and review of the literature. J Urol 102 (1969) 396-401
4. Van Slegtenhorst M., de Hoogt R., Hermans C., et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277 (1997) 805-808
5. The European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75 (1993) 1305-1315
6. Wienecke R., Konig A., and DeClue J.E. Identification of tuberin, the tuberous sclerosis-2 gene product. J Biol Chem 270 (1995) 16409-16414
7. Henske E.P., Neumann H.P., Scheithauer B.W., et al. Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes Cancer 13 (1995) 295-298
8. Martignoni G., Pea M., Reghellin D., et al. Perivascular epithelioid cell tumor (PEComa) in the genitourinary tract. Adv Anat Pathol 14 (2007) 36-41
9. Gould Rothberg B.E., Grooms M.C., and Dharnidharka V.R. Rapid growth of a kidney angiomyolipoma after initiation of oral contraceptive therapy. Obstet Gynecol 108 (2006) 734-736
10. Fernandez A.M., Minguez R., Serrano P., et al. Rapidly-growing renal angiomyolipoma associated with pregnancy. Actas Urol Esp 18 (1994) 755-757
11. King J.A., and Stamilio D.M. Maternal and fetal tuberous sclerosis complicating pregnancy: a case report and overview of the literature. Am J Perinatol 22 (2005) 103-108
12. Uzzo R.G., Libby D.M., Vaughan Jr. E.D., et al. Coexisting lymphangioleiomyomatosis and bilateral angiomyolipomas in a patient with tuberous sclerosis. J Urol 151 (1994) 1612-1615
13. Henske E.P., Ao X., Short M.P., et al. Frequent progesterone receptor immunoreactivity in tuberous sclerosis-associated renal angiomyolipomas. Mod Pathol 11 (1998) 665-668
14. L'Hostis H., Deminiere C., Ferriere J.M., et al. Renal angiomyolipoma: a clinicopathologic, immunohistochemical, and follow-up study of 46 cases. Am J Surg Pathol 23 (1999) 1011-1020
15. Logginidou H., Ao X., Russo I., et al. Frequent estrogen and progesterone receptor immunoreactivity in renal angiomyolipomas from women with pulmonary lymphangioleiomyomatosis. Chest 117 (2000) 25-30
16. Cho N.H., Shim H.S., Choi Y.D., et al. Estrogen receptor is significantly associated with the epithelioid variants of renal angiomyolipoma: a clinicopathological and immunohistochemical study of 67 cases. Pathol Int 54 (2004) 510-515
17. Fine S.W., Reuter V.E., Epstein J.I., et al. Angiomyolipoma with epithelial cysts (AMLEC): a distinct cystic variant of angiomyolipoma. Am J Surg Pathol 30 (2006) 593-599
18. Enmark E., Peltohuikko M., Grandien K., et al. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab 82 (1997) 4258-4265
19. Barkhem T., Carlsson B., Nilsson Y., et al. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol Pharmacol 54 (1998) 105-112
20. Nikaido T., Nakano M., Kato M., et al. Characterization of smooth muscle components in renal angiomyolipomas: histological and immunohistochemical comparison with renal capsular leiomyomas. Pathol Int 54 (2004) 1-9
21. Noronha R.F., and Rao B.R. Increased dihydrotestosterone receptor levels in high-stage renal adenocarcinoma. Cancer 56 (1985) 134-137
22. Langner C., Ratschek M., Rehak P., et al. Steroid hormone receptor expression in renal cell carcinoma: an immunohistochemical analysis of 182 tumors. J Urol 171 (2004) 611-614
23. Tickoo S.K., Gopalan A., Tu J.J., et al. Estrogen and progesterone-receptor-positive stroma as a non-tumorous proliferation in kidneys: a possible metaplastic response to obstruction. Mod Pathol 21 (2008) 60-65 Epub 2007 Sept 14
24. Yu J., Astrinidis A., Howard S., et al. Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways. Am J Physiol Lung Cell Mol Physiol 286 (2004) L694-L700
25. Karas R.H., Patterson B.L., and Mendelsohn M.E. Human vascular smooth muscle cells contain function estrogen receptor. Circulation 89 (1994) 1943-1950
26. Watanabe T., Akishita M., Nakaoka T., et al. Estrogen receptor beta mediates the inhibitory effect of estradiol on vascular smooth muscle proliferation. Cardiovasc Res 59 (2003) 734-744
27. Morales D.E., McGowan K.A., Grant D.S., et al. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 91 (1995) 755-763
28. Bausero P., Ben-Mahdi M., Mazucatelli J., et al. Vascular endothelial growth factor is modulated in vascular muscle cells by estradiol, tamoxifen, and hypoxia. Am J Physiol Heart Circ Physiol 279 (2000) H2033-H2042
29. Brugarolas J.B., Vazquez F., Reddy A., et al. TSC2 regulates VEGF through mTOR-dependent and -independent pathways. Cancer Cell 4 (2003) 147-158
30. El-Hashemite N., Walker V., and Kwiatkowski D.J. Estrogen enhances whereas tamoxifen retards development of TSC mouse liver hemangioma: a tumor related to renal angiomyolipoma and pulmonary lymphangioleiomyomatosis. Cancer Res 65 (2005) 2474-2481